Skip to main content
    L

    Lifestance Health Group Inc (LFST)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $14.48
    +0.40 (+2.84%)

    Market Cap: $5.35B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Lifestance Health Group Inc (LFST) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Lifestance Health Group (LFST) trades at 52.0x trailing earnings and 3.3x sales. Its P/B of 3.7x is above its 5-year median of 1.8x. Its forward P/E is 61.4x. The median P/E across 12 similar companies is 24.2x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 15.3% lower over the next year. Its free cash flow yield is 3.2%.

    MultipleValue
    P/E (trailing)52.0x
    Forward P/E61.4x
    Price to sales3.3x
    Price to book3.7x
    EV/EBITDA35.5x
    Price to FCF30.8x
    EV/FCF31.0x
    PEGN/A
    FCF yield3.2%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/B3.7x1.8xN/A
    Medians of month-end values through Oct 2026: 50 months (5-year).

    Valuation History

    Over the 3 of the 5 year ends shown that have a P/S, its P/S ranged from 1.9x in 2025 to 2.7x in 2023.

    Year endPriceP/EP/SP/B
    2025$7.0450.8x1.9x1.8x
    2024$7.37N/A2.2x1.9x
    2023$7.83N/A2.7x2.0x
    2022$4.94N/AN/A1.2x
    2021$9.52N/AN/A2.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About LFST

    What is LFST's forward P/E ratio?

    Lifestance Health Group has a forward P/E ratio of 61.4x.

    Is LFST stock overvalued?

    GNG's valuation label for LFST is Overvalued. Its P/E of 52.0x compares with a median of 24.2x across 12 similar companies.

    What is LFST's price to sales ratio?

    Lifestance Health Group has a price to sales ratio of 3.3x.